-The Hindu Business Line Through the ‘Sukrutham' scheme, the Kerala Government aims to take advanced Cancer treatment to the poorest Kerala: "We have two options, medically and emotionally: give up or fight like hell," Lance Armstrong, champion cycle racer, who recovered from advanced testicular Cancer once said about his battle against Cancer. The American, fortunately, had the money to pay for the extremely expensive treatment. But, for the majority of 1.75 lakh...
More »SEARCH RESULT
Total Matching Records found : 835
What is novelty? -Rajshree Chandra
-The Indian Express The era of globalised markets is also an era of globalised sovereignties. Nation states must constantly sync their policies with global constituencies of policies and citizens. At times, domestic disharmony is the price nation states may be required and willing to pay. The case in point here is the proposed review of the intellectual property rights (IPR) policy, particularly those clauses that are related to pharmaceutical patent policy....
More »Letter to PM about US-India Bilateral Relations on Intellectual Property
-Kafila.org Dear Prime Minister Modi ji, We, the undersigned, wish to share with you some of our concerns on India's position on intellectual property (IP), particularly in the context of bilateral relations between the United States of America and India. We gather from the US-India Joint Statement dated 30 September 2014 that the Indian Government (a)greeing on the need to foster innovation in a manner that promotes economic growth...
More »Urban women in 50s prone to breast Cancer -Malathy Iyer
-The Times of India MUMBAI: Debunking the popular belief that the incidence of breast Cancer is rising among India's younger women, doctors from Indian's premier Cancer hospital in Parel say the typical patient is, more often than not, in her 50s and lives in an urban area. "We have conducted a 20-year analysis of breast Cancer rates among the Indian population and found that while the rate of breast Cancer is definitely...
More »Pvt sector deserts war on TB, funding down 33% since 2011 -Subodh Varma
-The Times of India Even as tuberculosis (TB) continues to haunt the world, a new study has revealed that funding for research and development of new drugs to fight the disease is floundering. Private sector funding has declined by more than a third since 2011 as pharma companies are closing their TB research programmes. Pfizer shut down its TB drug discovery programme in 2012, AstraZeneca in 2013 and Novartis in 2014. Meanwhile,...
More »
